Skip to main content

Rigel Pharmaceuticals Inc 10-Q for FY2026 Q2

Rigel Pharmaceuticals Inc (RIGL)

10-Q 2026-08-04 For: 2026-06-30
View Original
Added on August 04, 2026

About this 10-Q

Rigel Pharmaceuticals Inc filed this 10-Q on August 4, 2026, covering the quarter ended June 30, 2026 (FY2026 Q2).

Headline figures

Quarter ended June 30, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$78.7M
down 22.6% from $101.69M a year earlier
Net income
$17.29M
down 71.0% from net income of $59.61M a year earlier
Diluted EPS
$0.88
down 73.2% from $3.28 a year earlier